Briana Contreras

Swimming in cold water can help ease menstrual and perimenopausal symptoms like anxiety and mood swings, according to a recent study published in Sage Journals.

Through investments made by the Bipartisan Safer Communities Act (BSCA), the grants will be awarded to 20 states of up to $2.5 million to support the implementation, improvement and expansion of school-based health services through Medicaid and the Children’s Health Insurance Program (CHIP).

The healthcare company will add new members to their teams while others expand their roles, and some retire from them.

Those who suffer from obesity, heavy smoking and short sleep have a higher chance of developing mass spectrometry (MS) and monoclonal gammopathy of undetermined significance (MGUS), which can often lead to multiple myeloma.

The smartphone app is currently under investigation in the CONVOKE study as a pharmaceutical therapy, aiming to address the negative symptoms associated with adult schizophrenia.

Researchers developed a new multi-cancer blood screening test to detect early-stage cancers and found it had a high level of accuracy.

Munson will succeed Paul A. Tufano, who served as the company’s CEO for almost a decade.

In this month’s episode, Briana Contreras, an editor of MHE, chatted with Lynn Carroll, executive of HSBlox, about the difference between predictive and generative AI, yet how each works together in preventive healthcare.

As the only FDA-approved, game-based digital therapeutic, EndeavorRx’s eligibility is expected to more than double the number of pediatric patients with ADHD who have a prescription from a healthcare provider, due to the increased age range.

Men with severe or moderately severe hemophilia B continue to display low bleeding rates and very little use of replacement therapies for at least three years following a single dose of the approved gene therapy hemgenix.

This expansion follows in response to the COVID-19 pandemic and its effect on rising mental health conditions in Massachusetts alone.

A recent study conducted by AHIP revealed that MA plans have been proven to provide better access to preventive healthcare, helping reduce disease risk and detecting illnesses early on.

Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?

The Fertility Out Loud docuseries by Ferring Pharmaceuticals is part of their Fertility Out Loud platform and social community designed to build awareness, provide education, and address the stigma associated with infertility.

Briana Contreras, an editor of Managed Healthcare Executive, spoke with Fred Turner, CEO of Curative, in this month’s episode about the challenges middle-class Americans face in dealing with medical debt, exploring the causes behind it and the impact on overall health.

PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.

In 2019, the worldwide burden of HCV exceeded 58 million people, with 14.9 million infections occurring in women aged 15 to 49 years.

Prior to the IRA, there were no limits on beneficiary OOP spending throughout the year. However, by 2025 the IRA will introduce the $2,000 maximum OOP expenses.

Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.

Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, spoke to MHE about the current disparities in diversity and ethnicity in rare disease clinical trials in the U.S., as well as what he's seeing in clinical trials for diseases like hemophilia, in specific.

COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.

This was found to be true in a cross-sectional study published in BMC, where 890 adults with HIV and 1,364 HIV-negative adults in China completed the trial through a self-administered online survey.

In recent years, the use of drone technologies and healthcare delivery has become a hot topic in scholarly discussions as they have attributed to address challenges associated with poor road conditions, transportation limitations and the need for more efficient responses to healthcare emergencies.

Wayne B. Batchelor, M.D., Associate Director of Inova Heart and Vascular Institute, discusses the latest advancements in less invasive techniques for treating pulmonary regurgitation.

Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.